Amy Dezern is an Oncology physician affiliated with Sidney Kimmel Comprehensive Cancer Center. OpenAlex indexes 498 publications with 11,002 citations (h-index 57); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
401 N Broadway St
Room 1363
Baltimore, MD 212870019
Telephone
410-955-8964Registry record last updated 25 Jan 2013.
Clinical trials
- NMA Haplo or MUD BMT for Newly Diagnosed Severe Aplastic Anemia
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- The National Myelodysplastic Syndromes (MDS) Study
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
- Shorter Course Tacro After NMA, Related Donor PBSCT With High-dose Posttransplant Cy for Hard-to-Engraft Malignancies
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
16 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Geron CorporationProgram year202510 payments$17,578openpaymentsdata.cms.gov ↗
- Agios Pharmaceuticals, Inc.Program year20251 payment
- PFIZER INC.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
35.7%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor23.3%Valacyclovir100%Part D≥23 patientsFluoroquinolone Antibacterial12.4%Levofloxacin55%Moxifloxacin Hcl45%Part D<11 patientsCancer & immunology
26.9%BCL-2 Inhibitor6.4%Venclexta100%Part D<11 patientsKinase inhibitor5.6%Jakafi100%Part D<11 patients+ 3 more classes in this area
Genitourinary & hormones
11.2%5-alpha Reductase Inhibitor5.6%Finasteride100%Part D<11 patientsalpha-Adrenergic Blocker5.6%Tamsulosin Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
4 NIH research awards on record, funded 2014–2025 per NIH RePORTER. The latest:
- Biologic and Therapeutic Consequences of Distinct Hotspot SF3B1 Mutations in MDS
Johns Hopkins University
FY2025$409,375R01HL159306 - Biologic and Therapeutic Consequences of Distinct Hotspot SF3B1 Mutations in MDS
Johns Hopkins University
FY2024$409,375R01HL159306 - Biologic and Therapeutic Consequences of Distinct Hotspot SF3B1 Mutations in MDS
Johns Hopkins University
FY2023$409,375R01HL159306
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- NCCN Guidelines® Insights: Myelodysplastic Syndromes, Version 3.2022
Journal of the National Comprehensive Cancer Network
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Donald Small, MD
Sidney Kimmel Comprehensive Cancer Center
Cesar Santa-Maria, MD
Sidney Kimmel Comprehensive Cancer Center
Javier Meade, MD
Sidney Kimmel Comprehensive Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”